trending Market Intelligence /marketintelligence/en/news-insights/trending/p-i3HvoboroBGfAwXCRajg2 content esgSubNav
In This List

OptimizeRx director resigns

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


OptimizeRx director resigns

OptimizeRx Corp. said board member Bryan Archambault resigned.

Archambault has been a director of the company since March. With the resignation, Archambault also resigned as a member of the board's audit, nomination and governance committees.

The Rochester, Mich.-based company said independent directors Patrick Spangler, James Lang and Ellen O'Connor Vos are expected to fill the roles left vacant by Archambault's departure.

The company operates a digital health messaging platform by using electronic health records to connect drugmakers with healthcare services providers.